(Q44705790)

5 December 2017

In vitro and in vivo activities of T-705 and oseltamivir against influenza virus (English)

1 reference

5 December 2017

1 reference

1 reference

Kazumi Takahashi

1

1 reference

5 December 2017

Yousuke Furuta

2

1 reference

5 December 2017

Yoshiko Fukuda

3

1 reference

5 December 2017

Masako Kuno

4

1 reference

5 December 2017

Tomoko Kamiyama

5

1 reference

5 December 2017

Kyo Kozaki

6

1 reference

5 December 2017

Nobuhiko Nomura

7

1 reference

5 December 2017

Hiroyuki Egawa

8

1 reference

5 December 2017

Shinzaburo Minami

9

1 reference

5 December 2017

Kimiyasu Shiraki

10

1 reference

5 December 2017

1 September 2003

1 reference

Antiviral Chemistry & Chemotherapy

5 December 2017

1 reference

5 December 2017

14

1 reference

5 December 2017

5

1 reference

5 December 2017

235-241

1 reference

Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir

5 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

In vitro and in vivo activities of anti-influenza virus compound T-705.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Influenza virus neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Therapeutic options for the management of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Evidence-based emergency medicine/systematic review abstract. Use of the neuraminidase inhibitor class of antiviral drugs for treatment of healthy adults with an acute influenza-like illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

Position statement: global neuraminidase inhibitor susceptibility network

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400502

10.1177/095632020301400502

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference